| Literature DB >> 28885570 |
Sonia Emanuele1, Marianna Lauricella2, Giuseppe Calvaruso3, Antonella D'Anneo4, Michela Giuliano5.
Abstract
Litchi is a tasty fruit that is commercially grown for food consumption and nutritional benefits in various parts of the world. Due to its biological activities, the fruit is becoming increasingly known and deserves attention not only for its edible part, the pulp, but also for its peel and seed that contain beneficial substances with antioxidant, cancer preventive, antimicrobial, and anti-inflammatory functions. Although literature demonstrates the biological activity of Litchi components in reducing tumor cell viability in in vitro or in vivo models, data about the biochemical mechanisms responsible for these effects are quite fragmentary. This review specifically describes, in a comprehensive analysis, the antitumor properties of the different parts of Litchi and highlights the main biochemical mechanisms involved.Entities:
Keywords: Litchi chinensis fruit extracts; antitumor activity; nutraceutical properties
Mesh:
Substances:
Year: 2017 PMID: 28885570 PMCID: PMC5622752 DOI: 10.3390/nu9090992
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Number of papers on Litchi chinensis biological activities published in the last seven years (font PubMed database, https://www.ncbi.nlm.nih.gov/pubmed).
Figure 2Sicilian Litchi chinensis tree, Kway May cultivar (a), Sicilian Litchi fruit. Kway May (b) and Way Chee (c) cultivars. The details of the pulp and seed are reported in (d,e), respectively (with the permission of Azienda Siciliana Cupitur, Caronia, Sicily).
Principal macronutrients and micronutrients of Litchi fruit.
| CALORIES | 66 kcal/100 g |
|---|---|
| MACROCOMPONENTS (g/100 g) | |
| Carbohydrates | 16.53 |
| Lipid | 0.44 |
| Protein | 0.83 |
| Dietary fiber | 1.30 |
| Water | 81.76 |
| MICROCOMPONENTS | |
| Total carotenoid content (μg beta-carotene equivalent/100 g) | 571.4 ± 117.2 |
| Vitamin C content (mg ascorbic acid equivalent/100 g) | 10.1 ± 2.2 |
| Total polyphenol content (mg gallic acid equivalent/100 g) | 178.0 ± 34.7 |
| Total flavonoid content (mg quercetin equivalent/100 g) | 53.3 ± 5.9 |
Figure 3Scheme of the effects of Litchi extracts on cell proliferation, cell survival, and apoptosis. Red arrows indicate downregulated factors or processes, and green arrows indicate increased factors or processes.
Specific antitumor effects of Litchi fruit portions and principal involved biochemical pathways.
| Cancer Model | Extracts or Specific Components | Antitumor Effect | Biochemical Pathways | References | ||
|---|---|---|---|---|---|---|
| Pulp | In vitro(cancer cell lines) | Lung adenocarcinoma, cervical cancer, hepatocellular carcinoma | Polysaccharides | Antiproliferative | Cell viability reduction | [ |
| Immunomodulatory | Induction of mouse splenocyte proliferation | |||||
| Gastric cancer, hepatocellular and lung carcinoma | Galactose and mannose | Antiproliferative | Cell viability reduction | [ | ||
| Antioxidant | Increase in cellular antioxidant activity | |||||
| In vivo(mice) | Chemical-induced liver injury | Pulp extract | Hepatoprotective | Decreased serum ALT and AST levels | [ | |
| Antioxidant | Changes in antioxidant enzyme levels | |||||
| Peel | In vitro(cancer cell lines) | Hepatocellular carcinoma | Water-soluble crude ethanolic extract | Antiproliferative | Cell viability reduction, clonogenic growth decrease | [ |
| Apoptosis induction | Pre G0/G1 pro-apoptotic peak in cell cycle profile | |||||
| Breast cancer cells | Water-soluble crude ethanolic extract | Antiproliferative | Cell viability reduction, Clonogenic growth decrease | [ | ||
| Apoptosis induction | Up and down-regulation of gene clusters involved in cell death | |||||
| Breast cancer cells | Specific flavonoid components | Antiproliferative | Cell viability reduction | [ | ||
| In vivo | Murine hepatoma bearing-mice | Inhibition of tumor growth | Reduction in cell proliferation | [ | ||
| Nude mice bearing human breast infiltrating duct carcinoma | Water-soluble crude ethanolic extract | Tumor mass reduction | Reduction in cell proliferation | [ | ||
| Apoptosis induction | Caspase-3 activation | |||||
| Seed | In vitro(cancer cell lines) | Lung adenocarcinoma, cervical, breast, ovarian cancers and hepatocellular carcinoma | Flavonoid glycosides | Anti proliferative | Cell viability reduction | [ |
| Hepatocellular, lung and cervical carcinoma | Sesquiterpene glucosides | Anti proliferative | Cell viability reduction | [ | ||
| Non-small cell lung cancer | Crude Litchi extract | Anti proliferative | Inhibition of EGF-receptor-pathway | [ | ||
| Apoptosis induction | Bcl-2 family pro-apoptotic ratio and caspase activation | |||||
| Colorectal carcinoma | Flavonoids and tannins | Anti proliferative | G2/M phase cell cycle arrest with reduction in cyclin levels | [ | ||
| Apoptosis induction | Increase in Bax level and caspase activation | |||||
| Prostate cancer | N-butyl alcohol extract | Anti proliferative | Clonogenic growth decrease, G1/S phase Cell cycle arrest with increase in p21 and p27 CDK inhibitors | [ | ||
| Apoptosis induction | Activation of mitochondrial caspase cascade | |||||
| Decrease in cell migration and invasion | Increase in E-cadherin and â-catenin, decrease of vimentin and snail, inhibition of Akt pathway | |||||
| Hepatocellular carcinoma | Semen Litchi containing serum | Anti proliferative | Cell viability reduction | [ | ||
| Apoptosis induction | Appearance of nuclear morphological features and pre G0/G1 pro-apoptotic peak in cell cycle profile | |||||
| In vivo | mouse xenografts of Ehrlich ascites cells, sarcoma S180 cells, or liver tumor cells | Water extract | Decrease in tumor size | [ | ||
| hyperplasia of mammary glands rat model | Saponins | Reduction of mammary gland hyperplasia | [ | |||
| Nude mice xenograft of PC3 cells | n-butyl alcohol extract | Decrease in tumor size | [ | |||
| Oligonol | In vitro | Breast cancer cells | Low MW polyphenols from lychee fruit extract | Apoptosis induction | Modulation of pro-apoptotic Bcl-2 family proteins and MEK/ERK signaling pathway | [ |
| In vivo | DSS-promoted adenoma in the mouse colon | Inhibition of colonic adenoma formation | Reduction of cyclins | [ | ||
| Variation of oxidative stress markers | ||||||
| Melanoma mice models | Inhibition of lung metastasis | Inhibition of lung hexosammine content, and serum sialic acid and gamma glutamyltranspeptidase content | [ | |||
| Mouse skin and carcinomas and papillomas bearing mice | Suppression of chemically-induced tumorigenesis | NF-êB and C/EBP DNA binding decrease, reduction of ERK 1/2 and P38 kinases, reduction in PCNA and COX2 | [ | |||